✦ LIBER ✦

p53MVA Therapy in Patients with Refractory Gastrointestinal Malignancies Elevates p53-Specific CD8+ T-cell Responses

✍ Scribed by Hardwick, N. R.; Carroll, M.; Kaltcheva, T.; Qian, D.; Lim, D.; Leong, L.; Chu, P.; Kim, J.; Chao, J.; Fakih, M.; Yen, Y.; Espenschied, J.; Ellenhorn, J. D. I.; Diamond, D. J.; Chung, V.

Book ID: 126158958
Publisher: American Association for Cancer Research
Year: 2014
Tongue: English
Weight: 730 KB
Volume: 20
Category: Article
ISSN: 1078-0432
DOI: 10.1158/1078-0432.CCR-13-3361

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

p53-specific CD8+ T-cell responses in in

p53-specific CD8+ T-cell responses in individuals with cutaneous squamous cell carcinoma

✍ A.P. Black; A. Bailey; L. Jones; R.J. Turner; K. Hollowood; G.S. Ogg 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 380 KB

P53-specific T cell responses in patient

P53-specific T cell responses in patients with malignant and benign ovarian tumors: Implications for p53 based immunotherapy

✍ Annechien Lambeck; Ninke Leffers; Baukje-Nynke Hoogeboom; Wim Sluiter; Ineke Ham 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 214 KB

## Abstract Despite intensive treatment, 70% of the ovarian cancer patients will develop recurrent disease, emphasizing the need for new approaches such as immunotherapy. A promising antigenic target for immunotherapy in ovarian cancer is the frequently overexpressed p53 protein. The aim of the stu

Immune responses to p53 in patients with

Immune responses to p53 in patients with cancer:enrichment in tetramer+ p53 peptide-specific T cells and regulatory T cells at tumor sites

✍ Andreas E. Albers; Robert L. Ferris; Grace G. Kim; Kazuaki Chikamatsu; Albert B. 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 380 KB

Long lasting p53-specific T cell memory

Long lasting p53-specific T cell memory responses in the absence of anti-p53 antibodies in patients with resected primary colorectal cancer

✍ Sjoerd H. van der Burg; Karin de Cock; Anand G. Menon; Kees L. M. C Franken; Mar 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 1 views

CD4+ T cell responses to HLA-DP5-restric

CD4+ T cell responses to HLA-DP5-restricted wild-type sequence p53 peptides in patients with head and neck cancer

✍ Kazuaki Chikamatsu; Koichi Sakakura; Goro Takahashi; Atsushi Okamoto; Nobuhiko F 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 415 KB

p21-ras-peptide-specific T-cell response

p21-ras-peptide-specific T-cell responses in a patient with colorectal cancer. CD4+ and CD8+ T cells recognize a peptide corresponding to a common mutation (13Gly → Asp)

✍ Beate Fossum; Tobias Gedde-Dahl III; Jarle Breivik; Jon Amund Eriksen; Anne Spur 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 979 KB

Peptides derived from mutated ras are immunogenic in mice and humans, and represent a group of specific tumor antigens that are potential targets for immunotherapy. T-cell responses against mutant p2I ras can be initiated in vitro by repeated stimulation of peripheral-blood mononuclear cells with mu